Related Experiment Video
Updated: Mar 26, 2026

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Direct comparison of clinical decision limits for cardiac troponin T and I
Dorien M Kimenai1, Ronald M A Henry2, Carla J H van der Kallen2
1Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Insights
High-sensitivity cardiac troponin (hs-cTn) thresholds for diagnosing heart attacks are similar between assays, despite current differences. Adjusting hs-cTnI limits for sex could prevent underdiagnosis, especially in women.
Area of Science:
- Cardiology
- Biomarker analysis
- Clinical diagnostics
Background:
- Current diagnostic thresholds for high-sensitivity cardiac troponin T (hs-cTnT) and troponin I (hs-cTnI) assays differ (14 ng/L and 26 ng/L, respectively).
- These thresholds were established using separate reference populations, raising questions about their biological equivalence.
- Understanding assay-specific reference limits is crucial for accurate acute myocardial infarction (AMI) diagnosis.
Purpose of the Study:
- To directly compare sex- and age-specific 99th percentile upper reference limits for hs-cTnT and hs-cTnI within a single reference cohort.
- To investigate whether current divergent hs-cTnT and hs-cTnI thresholds are due to intrinsic assay differences or cohort variations.
- To inform potential adjustments in diagnostic criteria for AMI.
Main Methods:
- A healthy reference population (n=1540) was selected from the Maastricht Study (n=3451), aged 40-75 years.
- Exclusion criteria included diabetes, cardiovascular disease history, ECG abnormalities, elevated NT-proBNP, or reduced estimated glomerular filtration rate.
- Non-parametric statistical methods were used to determine 99th percentile upper reference limits.
Main Results:
- Overall 99th percentile upper reference limits were 15 ng/L for hs-cTnT and 13 ng/L for hs-cTnI.
- Reference limits were higher in men than women for both assays (hs-cTnT: 16 vs 12 ng/L; hs-cTnI: 20 vs 11 ng/L).
- Upper reference limits demonstrated an increasing trend with age for both hs-cTnT and hs-cTnI.
Conclusions:
- Numerically similar thresholds for hs-cTnT and hs-cTnI assays were observed upon direct comparison.
- The current hs-cTnI threshold of 26 ng/L may lead to underdiagnosis of AMI, particularly in women.
- Sex-differentiated downward adjustment of the hs-cTnI threshold could align clinical decision limits and improve AMI detection.
Objective:
The 99th percentile upper reference limit of high-sensitivity cardiac troponin (hs-cTn) from a healthy reference population is used for diagnosing acute myocardial infarction (AMI). Accepted current thresholds of hs-cTnT (Roche) and hs-cTnI (Abbott) are 14 and 26 ng/L, respectively. Since thresholds for hs-cTnT and hs-cTnI were derived from different reference cohorts it is unclear whether they are biologically equivalent. We directly assessed sex-specific and age-specific 99th percentile upper reference limits of hs-cTnT and hs-cTnI in a single reference cohort, to investigate whether current divergent thresholds of hs-cTnT and hs-cTnI stem from intrinsic assay differences or reflect cohort variation.
Methods:
A healthy reference population was derived from a population-based cohort (the Maastricht Study: n=3451; age: 40-75 years). Individuals with diabetes mellitus, a history of cardiovascular disease, cardiac ischaemia on ECG, N-terminal pro-brain natriuretic peptide >125 ng/L or estimated glomerular filtration rate <60 mL/min/1.73 m(2) were excluded. Non-parametric analyses were performed to assess 99th percentile upper reference limits.
Results:
1540 individuals were included in the healthy reference population (age 57±8 years, 52.4% women). Overall 99th percentile upper reference limits of hs-cTnT and hs-cTnI were 15 and 13 ng/L, respectively. Upper reference limits were higher in men than women (hs-cTnT: 16 vs 12 ng/L), (hs-cTnI: 20 vs 11 ng/L) and increased with age.
Conclusions:
Direct comparison reveals numerically similar thresholds for hs-cTnT and hs-cTnI assays. This finding is in line with recently reported underdiagnosis of AMI with the current decision limit of 26 ng/L for hs-cTnI, especially among women. Downwards adjustment of the hs-cTnI threshold, differentiated for sex, would equalise clinical decision limits for both assays, and may prevent further underdiagnosis of AMI.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Comparing Experimental Results: Student's t-Test
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Therapeutic Index